Safety and Feasibility of the ELIOS System in POAG Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Iqbal (Ike) Ahmed, MD
Prism Eye Institute
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Elios Vision Clinical Site
Glendale, Arizona, United States
- Elios Vision Clinical Site
Rock Island, Illinois, United States
- Elios Vision Clinical Site
St Louis, Missouri, United States
- Elios Vision Clinical Site
Oklahoma City, Oklahoma, United States
- Elios Vision Clinical Site
El Paso, Texas, United States
- Elios Vision Clinical Site
Kenosha, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Oct 2023
- Primary completion
- 28 Apr 2026
- Completion
- 28 Apr 2026
- Last update posted
- 16 Jun 2026
- Registered enrollment
- 22
- Registry id
- NCT05999006
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.